Department of General Surgery, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
Department of Surgical Oncology, Edward-Elmhurst Health, Naperville, IL, USA.
Surg Endosc. 2024 May;38(5):2602-2610. doi: 10.1007/s00464-024-10783-1. Epub 2024 Mar 18.
Minimally invasive Pancreatoduodenectomy (MIPD), or the Whipple procedure, is increasingly utilized. No study has compared laparoscopic (LPD) and robotic (RPD) approaches, and the impact of the learning curve on oncologic, technical, and post-operative outcomes remains relatively understudied.
The National Cancer Database was queried for patients undergoing LPD or RPD from 2010 to 2020 with a diagnosis of pancreatic cancer. Outcomes were compared between approaches using propensity-score matching (PSM); the impact of annual center-level volume of MIPD was also assessed by dividing volume into quartiles.
A total of 3,342 patients were included. Most (n = 2,716, 81.3%) underwent LPD versus RPD (n = 626, 18.7%). There was a high rate (20.2%, n = 719) of positive margins. Mean length-of-stay (LOS) was 10.4 ± 8.9 days. Thirty-day mortality was 2.8% (n = 92) and ninety-day mortality was 5.7% (n = 189). PSM matched 625 pairs of patients receiving LPD or RPD. After PSM, there was no differences between groups based on age, sex, race, CCI, T-stage, neoadjuvant chemo/radiotherapy, or type of PD. After PSM, there was a higher rate of conversion to open (HR = 0.68, 95%CI = 0.50-0.92)., but there was no difference in LOS (HR = 1.00, 95%CI = 0.92-1.11), 30-day readmission (HR = 1.08, 95% CI = 0.68-1.71), 30-day (HR = 0.78, 95% CI = 0.39-1.56) or 90-day mortality (HR = 0.70, 95% CI = 0.42-1.16), ability to receive adjuvant therapy (HR = 1.15, 95% CI = 0.92-1.44), nodal harvest (HR = 1.01, 95%CI = 0.94-1.09) or positive margins (HR = 1.19, 95% CI = 0.89-1.59). Centers in lower quartiles of annual volume of MIPD demonstrated reduced nodal harvest (p = 0.005) and a higher rate of conversion to open (p = 0.038). Higher-volume centers had a shorter LOS (p = 0.012), higher rate of initiation of adjuvant therapy (p = 0.042), and, most strikingly, a reduction in 90-day mortality (p = 0.033).
LPD and RPD have similar surgical and oncologic outcomes, with a lower rate of conversion to open in the robotic cohort. The robotic technique does not appear to eliminate the "learning curve", with higher volume centers demonstrating improved outcomes, especially seen at minimum annual volume of 5 cases.
微创胰十二指肠切除术(MIPD),即 Whipple 手术,应用越来越广泛。目前还没有研究比较腹腔镜(LPD)和机器人(RPD)方法,学习曲线对肿瘤学、技术和术后结果的影响仍相对研究不足。
从 2010 年至 2020 年,国家癌症数据库中检索诊断为胰腺癌并接受 LPD 或 RPD 的患者。使用倾向评分匹配(PSM)比较两种方法的结果;还通过将 MIPD 的年度中心容量分为四等分来评估中心容量的影响。
共纳入 3342 例患者。大多数患者(n=2716,81.3%)接受了 LPD,而接受 RPD 的患者(n=626,18.7%)较少。阳性切缘率较高(20.2%,n=719)。平均住院时间(LOS)为 10.4±8.9 天。30 天死亡率为 2.8%(n=92),90 天死亡率为 5.7%(n=189)。PSM 匹配了 625 对接受 LPD 或 RPD 的患者。PSM 后,两组在年龄、性别、种族、CCI、T 期、新辅助化疗/放疗和 PD 类型方面没有差异。PSM 后,转为开放手术的比例更高(HR=0.68,95%CI=0.50-0.92)。但 LOS(HR=1.00,95%CI=0.92-1.11)、30 天再入院(HR=1.08,95%CI=0.68-1.71)、30 天(HR=0.78,95%CI=0.39-1.56)或 90 天死亡率(HR=0.70,95%CI=0.42-1.16)、接受辅助治疗的能力(HR=1.15,95%CI=0.92-1.44)、淋巴结清扫(HR=1.01,95%CI=0.94-1.09)或阳性切缘(HR=1.19,95%CI=0.89-1.59)无差异。年度 MIPD 容量较低的中心表现出淋巴结清扫减少(p=0.005)和转为开放手术的比例较高(p=0.038)。高容量中心的 LOS 更短(p=0.012),辅助治疗的起始率更高(p=0.042),最显著的是 90 天死亡率降低(p=0.033)。
LPD 和 RPD 具有相似的手术和肿瘤学结果,机器人组转为开放手术的比例较低。机器人技术似乎并没有消除“学习曲线”,高容量中心的表现更好,特别是每年至少进行 5 例手术。